Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Economy & Forex  >  All News

News : Economy & Forex
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies / ForexCryptocurrenciesEconomic EventsPress releases

EU support for New Nordic Life Science Venture Fund, Eir Ventures

share with twitter share with LinkedIn share with facebook
07/13/2020 | 05:41am EDT

Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new Fund of EUR 76 million. Eir Ventures will invest in innovative companies with products and technologies that address significant unmet medical needs and have the potential to improve the life of patients. The fund is launched with, among other investors, a EUR 20 million investment from the European Investment Fund (EIF), made possible under the European Fund for Strategic Investments, main pillar of the Investment Plan for Europe.

Eir Ventures is launched by four senior life science investors, Dr Magnus Persson, Stephan Christgau, Andreas Segerros are the Managing partners, and Amanda Hayward is special partner. The Fund is domiciled in Sweden and will have offices in Stockholm and Copenhagen. The fund will invest in high return potential opportunities in the Nordics, in Europe as well as in the US, but with a particular focus on innovations from the leading universities and incubators in the Nordics. Eir Ventures has already established collaborations with select Nordic Universities.

'The COVID-19 pandemic has been a powerful illustration that healthcare is a truly global issue, and that there is a constant need for new treatments and therapies. Hence, it is essential that we invest in emerging companies that develops new treatments emerging from Danish and Nordic University innovation and life science entrepreneurs in the region. I am thrilled that Vækstfonden can help launch and fund Eir Ventures.' Says Simon Kollerup, Danish Minister of Industry, Business and Financial affairs.

'This EIF investment reflects the importance of sustaining innovative players in this sector, made all the more crucial by the ongoing situation. Eir Ventures has a strong founder team and the fund will be well-positioned to find and further develop companies that solve tomorrow's health challenges.' says Alain Godard, Chief Executive at the European Investment Fund.

Managing Partner DrMagnus Persson added 'In the current environment, where financing has become even more sparse and start-ups are struggling to fund development, and where healthcare innovation is more important than ever, we see great potential to bring some of the highly innovative treatments to patients with underserved medical needs, while also bringing outstanding returns to our investors'.

Managing Partner Stephan Christgau commented 'The Nordic region is year after year ranked as one of the most innovative areas in Europe, with a stable business environment and a great legacy of medical innovation, yet the region is severely underserved with professional venture capital. We see this as a unique opportunity that Eir Ventures will leverage.'

Eir Ventures will have offices in Stockholm and Copenhagen.

Background information:

Eir Ventures is a Life science focused venture fund, that with a strong foundation in the Nordic Biotech ecosystem will invest in early stage as well as more mature opportunities. The fund initiates investment activities in 2020 and will seek opportunities addressing significant unmet medical needs for new therapies, medical technology and digital health. The fund is registered in Sweden and has offices in Stockholm and Copenhagen.

The European Investment Fund (EIF) is part of the European Investment Bank Group. Its central mission is to support Europe's micro, small and medium-sized businesses (SMEs) by helping them to access finance. EIF designs and develops venture and growth capital, guarantees and microfinance instruments which specifically target this market segment. In this role, EIF fosters EU objectives in support of innovation, research and development, entrepreneurship, growth, and employment.

The European Fund for Strategic Investments (EFSI) is the main pillar of the Investment Plan for Europe. It provides first loss guarantees enabling the EIB to invest in more, often riskier projects. The projects and agreements approved for financing under EFSI are expected to mobilise €486 bn in investment, supporting over 1.2 million start-ups and SMEs across the EU.

Press Contacts:

Eir Ventures:

Magnus Persson +46 737314146, magnus.persson@eirventures.eu
Stephan Christgau +45 30674790, Stephan.christgau@eirventures.eu
Website : www.eirventures.eu

European Commission:

Siobhán Millbright, +32 460 75 73 61, Siobhan.millbright@ec.europea.eu

EIB Group:

Tim Smit, Tel: +352 691 28 64 23, t.smit@eib.org, Follow us on Twitter
Website: www.eib.org/press - Press Office: +352 4379 21000 - press@eib.org


EIF - European Investment Fund published this content on 10 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 July 2020 09:40:07 UTC

share with twitter share with LinkedIn share with facebook
Latest news "Economy & Forex"
12:34aAustralia's AGL sees bigger-than-expected profit drop, shares dive over 10%
12:23aMAS MONETARY AUTHORITY OF SINGAPORE : Commits S$250 Million to Accelerate Innovation and Technology Adoption in Financial Sector
12:16aNEWS HIGHLIGHTS : Top Financial Services News of the Day
08/12China's banking sector expected to dispose $490 bln of bad loans in 2020 - Xinhua
08/12NEWS HIGHLIGHTS : Top Company News of the Day
08/12NEWS HIGHLIGHTS : Top Global Markets News of the Day
08/12Australia, NZ dlrs edge up, jobs data upbeat but with caveats
08/12Philippines says Shell refinery shutdown will not impact local oil supply
08/12China's July air passenger numbers fall 34.1% year-on-year - regulator
08/12Dollar grinds lower as traders question timing of U.S. stimulus
Latest news "Economy & Forex"